MPM BIOIMPACT LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1687078 BOSTON, MA

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$63,782,348

+$30,110,074 QoQ

Shares Held

1,122,731

-0.9% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

3.89%

of 13F equity value

Holder Rank

#27

of 317 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. TVTX ranks #6 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGEM	Cullinan Therapeutics, Inc.	9,731,341	$177,207,719
2	AKTS	Aktis Oncology, Inc.	4,835,872	$155,860,154
3	RVMD	Revolution Medicines, Inc.	492,483	$92,232,216
4	CORT	Corcept Therapeutics Inc	771,028	$67,040,884
5	EWTX	Edgewise Therapeutics, Inc.	1,620,780	$65,852,291
6	TVTX	Travere Therapeutics, Inc. This page	1,122,731	$63,782,348
7	DBVT	DBV Technologies S.A.	3,666,284	$60,127,057
8	TRVI	Trevi Therapeutics, Inc.	3,073,577	$57,322,211

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$63,782,348	1,122,731	-0.9%	Shares	Sole	2026-08-14
2026-03-31	$33,672,274	1,133,365	+105.0%	Shares	Sole	2026-05-15
2023-09-30	$4,942,443	552,846	0.0%	Shares	Sole	2023-11-14
2023-06-30	$8,491,714	552,846	+76.3%	Shares	Sole	2023-08-14
2023-03-31	$7,053,808	313,642	+11.3%	Shares	Sole	2023-05-12
2022-12-31	$5,924,382	281,711	+1.9%	Shares	Sole	2023-02-14
2022-09-30	$6,811,974	276,460	-0.5%	Shares	Sole	2022-11-14
2022-06-30	$6,734,728	277,950	0.0%	Shares	Sole	2022-08-11
2022-03-31	$7,162,771	277,950	-3.5%	Shares	Sole	2022-05-13
2021-12-31	$8,936,198	287,893	-6.1%	Shares	Sole	2022-02-11
2021-09-30	$7,432,988	306,515	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.